Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities:
Net (loss) income	$ (6,458)	$ 8,576
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	17,002	15,230
Share-based Compensation	1,442	1,204
Asset Impairment Charges	0	4,222
Contingent consideration write-off	0	(7,950)
Write off of Deferred Debt Issuance Cost	8,464	0
Deferred Income Tax Expense (Benefit)	147	3,091
payments for hedge, operating activities	(793)	0
Other noncash items	(87)	(326)
Changes in operating assets and liabilities:
Accounts receivable	8,187	(17,835)
Inventories	2,079	(22,698)
Prepaid expenses and other assets	2,003	233
Current income taxes	(2,899)	(29)
Accounts payable	785	(4,951)
Accrued expenses	6,144	2,637
Net cash provided (used) by operating activities	36,016	(18,596)
Investing activities:
Additions to property, plant and equipment	(10,302)	(21,230)
Proceeds from sale of property, plant, and equipment	981	1,942
Net cash used by investing activities	(9,321)	(19,288)
Financing activities:
Proceeds from issuance of debt	250,000	6,160
Principal payments on long-term debt and notes payable	(231,898)	(4,766)
Advances on revolving line of credit	60,000	112,000
Payments on revolving line of credit	(96,000)	(78,000)
Payments of Debt Issuance Costs	(7,881)	0
Other, net	(28)	(304)
Net cash (used) provided by financing activities	(25,807)	35,090
Net increase (decrease) in cash and cash equivalents	888	(2,794)
Cash and cash equivalents, beginning of period	1,572	4,347
Cash and cash equivalents, end of period	2,460	1,553
Supplemental disclosure of noncash transactions:
Acquisition purchase price adjustment	0	1,219
Defined contribution plan funding in Company stock	$ 848	$ 901